Selection of large diversities of antiidiotypic antibody fragments by phage display

Journal of Molecular Biology

Volumn 315, Issue 5, 2002, Pages 1087-1097

  Goletz, Steffen ^a,b   Christensen, Peter Astrup ^a,b   Kristensen, Peter ^c   Blohm, Dietmar ^d   Tomlinson, Ian ^e   Winter, Greg ^e   Karsten, Uwe ^a,b  

^a NEMOD GmbH   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF BREMEN   (Germany)

^e MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

Author keywords

Antibody engineering; Antiidiotypic antibodies; Molecular mimicry; Phage display; scFv

Indexed keywords

ANTIGEN; ANTIIDIOTYPIC ANTIBODY; CARBOHYDRATE DERIVATIVE; DISACCHARIDE; EPITOPE; GLYCINE; TRYPSIN;

ANTIBODY LIBRARY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CLONE; ELUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; PH; PHAGE DISPLAY; PHAGEMID; PRIORITY JOURNAL; PROTEIN CONFORMATION;

EID: 0036301031     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.5314     Document Type: Article

References (38)

1. Towards a network theory of the immune system
2. Anti-idiotype vaccine against cancer
3. Advances in cancer vaccine development
4. Mimicry of human IgE epitopes by anti-idiotypic antibodies
5. Anti-idiotypic antibodies that mimic the colorectal cancer antigen CO17-1A/GA733: Twelce years of pre-clinical and clinical studies
6. Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes
7. T cell-independent antigens type 2
8. A neoadjucnat clinicla trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55
9. Long survival of patients with small cell lung cancer after adjuvant treatment cith the anti-idiotypic antibody BAC2 plus Bacillus Calmette-Guérin
10. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface
11. Phage antibodies: Filamentous phage displaying antibody variable domains
12. Making antibodies by phage display technology
13. By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro
14. By-passing immunization. Human antibodies from V-gene libraries displayed on phage
15. Proteolytic selection for protein folding using filamentous bacteriophages
16. Novel folded protein domains generated by combinatorial shuffling of polypeptide segments
17. Antibody arrays for high-throughput screening of antibody-antigen interactions
18. A strategy for the isolation of catalytic activities from repetoires of enzymes displayed on phage
19. Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display
20. Idenfication of phage antibodies toward the Werner protein by selection on Western blots
21. Coupling protein design and in vitro selection strategies: Improving specificity and affinity of a designed beta-protein IL-6 antagonist
22. Selection of phage-displayed antibodies specific for a cyto-skeletal antigen by competitive elution with a monoclonal antibody
23. Selection of phage antibodies by binding affinity. Mimicking affinity maturation
24. Toward selection of internalizing antibodies from phage libraries
25. A helper phage to improve single-chain antibody presentation in phage display
26. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis
27. Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2
28. Characterization of phage-displayed recombinant anti-idiotypic antibody fragments against coronavirus-neutralizing monoclonal antibodies
29. Modulation of the murine immune response to streptococcal group A carbohydrate by immunization with monoclonal anti-idiotope
30. Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2
31. Summary report on the ISOBM TD-4 Workshop: Analysis of 56 mono-clonal antibodies against the MUC1 mucin
32. Enhanced binding of antobodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation
33. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen
34. Isolation of high affinity human antibodies directly from large synthetic repertoires
35. Antibody fragments from a "single pot" phage display library as immunochemical reagents
36. Novel αGalNAc containing glycans on cytokeratins are recognized in vitro by galectins with type II carbohydrate recognition domains
37. The C-terminal domain of TolA is the coreceptor for filamentous phage infection of E. coli
38. Selectively-infective phage (SIP): A mechanistic dissection of a novel in vivo selection for protein-ligand interactions